BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2216293)

  • 1. Cerebrospinal fluid content of manganese, platinum, and strontium in patients with cerebral tumors, leukemia, and other noncerebral neoplasms.
    el-Yazigi A; Kanaan I; Martin CR; Siqueira EB
    Oncology; 1990; 47(5):385-8. PubMed ID: 2216293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of chromium, cesium, and tin in cerebrospinal fluid of patients with brain neoplasms, leukemia or other noncerebral malignancies, and neurological diseases.
    el-Yazigi A; Martin CR; Siqueira EB
    Clin Chem; 1988 Jun; 34(6):1084-6. PubMed ID: 3378324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy markers in the cerebrospinal fluid.
    Koskiniemi M
    Eur J Pediatr; 1988 Oct; 148(1):3-8. PubMed ID: 3058481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytodiagnosis of malignant lesions in cerebrospinal fluid. Review and cytohistologic correlation.
    An-Foraker SH
    Acta Cytol; 1985; 29(3):286-90. PubMed ID: 3859125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytological findings of the cerebrospinal fluid at diagnosis of acute lymphocytic leukemia in children--effect of remission induction chemotherapy].
    Kinumaki H; Bessho F; Yokota S
    Rinsho Ketsueki; 1989 Oct; 30(10):1763-8. PubMed ID: 2593242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
    Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
    Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
    Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cerebrospinal fluid glutamine levels in patients with benign brain tumors.
    el-Yazigi A; Al-Mefty O
    J Neurochem; 1985 Sep; 45(3):815-8. PubMed ID: 4031863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children.
    Yule SM; Price L; Pearson AD; Boddy AV
    Clin Cancer Res; 1997 Nov; 3(11):1985-92. PubMed ID: 9815588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of zinc, iron, molybdenum, arsenic, and lithium in cerebrospinal fluid of patients with brain tumors.
    el-Yazigi A; Al-Saleh I; Al-Mefty O
    Clin Chem; 1986 Dec; 32(12):2187-90. PubMed ID: 3779980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese and selenium concentrations in cerebrospinal fluid of seriously ill children.
    Franěk T; Kotaška K; Průša R
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28205254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid ferritin in patients with leukaemia and malignant lymphoma.
    Milman N; Vig L; Pedersen NS; Olsen TS
    Scand J Haematol; 1985 Aug; 35(2):132-6. PubMed ID: 3863234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transthyretin and albumin in cerebrospinal fluid in patients with acute leukemias or lymphomas of high grade malignancy].
    Millo B; Zdziarska B; Nowacki P
    Acta Haematol Pol; 1996; 27(1):73-7. PubMed ID: 8629447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Content of manganese and magnesium in the blood and cerebrospinal fluid in patients with brain tumors in the pre- and postoperative period].
    Shevaga VN
    Vrach Delo; 1973 Nov; 11():111-4. PubMed ID: 4786907
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
    Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
    Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.
    DeGregorio M; Wilbur B; King O; Wallenberg J; Prewitt S; Phillips J; Wilbur J
    Cancer Treat Rep; 1986 Dec; 70(12):1437-8. PubMed ID: 3791256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
    Chang CS; Liu HW; Lin SF; Chen TP
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebrospinal fluid studies in acute lymphoblastic leukemia and lymphosarcomas in children].
    Bondarenko LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(5):56-7. PubMed ID: 8154221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.
    DeGregorio MW; King OY; Holleran WM; Wilbur BJ; Cadman EC; Deisseroth AB; Wilbur JR
    Cancer Treat Rep; 1985 Dec; 69(12):1441-2. PubMed ID: 4075318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.